Home › Trial NCT02618538
The Andromeda Study.Predictive Value of Combined Criteria to Tailor Breast Cancer Screening.
- Trial IDNCT02618538
- StatusCompleted
- PhaseN/A
- Study typeObservational
- SponsorCentro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte
- Enrollment26600
- Start date2015-07
- ConditionsBreast Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.